ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONVO Organovo Holdings Inc

0.907
0.0012 (0.13%)
Last Updated: 14:28:30
Delayed by 15 minutes

Period:

Draw Mode:

Volume 87,402
Bid Price 0.907
Ask Price 0.926
News -
Day High 0.9279

Low
0.85

52 Week Range

High
2.05

Day Low 0.896
Share Name Share Symbol Market Stock Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0012 0.13% 0.907 14:28:30
Open Price Low Price High Price Close Price Previous Close
0.90 0.896 0.9279 0.9058
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
501 87,402 US$ 0.9148457 US$ 79,959 - 0.85 - 2.05
Last Trade Type Quantity Price Currency
14:38:03 4 US$ 0.9165 USD

Organovo Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.14M 10.04M - 109k -14.67M -1.46 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Organovo News

Date Time Source News Article
5/31/202415:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
5/21/202407:05GlobeNewswire Inc.Organovo Data Presented at Digestive Disease Week (DDW2024)..
5/14/202411:45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]
5/14/202410:00GlobeNewswire Inc.Organovo to Present Data on FXR314 at Digestive Diseases..
5/13/202416:00Edgar (US Regulatory)Form 8-K - Current report
5/10/202416:15Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]
5/08/202419:00GlobeNewswire Inc.Organovo Holdings, Inc. Announces Pricing of $5.25 Million..
4/15/202407:05GlobeNewswire Inc.Organovo Announces Positive Phase 2 Results for FXR314 in..
2/08/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
2/08/202415:56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/202407:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ONVO Message Board. Create One! See More Posts on ONVO Message Board See More Message Board Posts

Historical ONVO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.971.090.890.9469319172,634-0.063-6.49%
1 Month1.051.100.890.988534125,956-0.143-13.62%
3 Months1.001.740.851.291,124,198-0.093-9.30%
6 Months1.251.740.851.27598,496-0.343-27.44%
1 Year1.812.050.851.29349,152-0.903-49.89%
3 Years8.419.890.851.99160,093-7.50-89.22%
5 Years0.50223.920.19332.22366,5340.40580.68%

Organovo Description

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Your Recent History

Delayed Upgrade Clock